Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia

Neurology

Volumn 60, Issue 12, 2003, Pages 2013-2014

  Squitti, R ^a,d   Pasqualetti, P ^a   Cassetta, E ^a   Dal Forno, G ^a,b   Cesaretti, S ^a   Pedace, F ^a   Finazzi Agro A ^c   Rossini, P M ^a,d  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; IRON; PEROXIDE; TRANSFERRIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; GENOTYPE; HOMEOSTASIS; HUMAN; LABORATORY TEST; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; OXIDATIVE STRESS; PRIORITY JOURNAL; SCORING SYSTEM; SENILE PLAQUE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 0037700234     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000068013.27968.29     Document Type: Article

References (7)

1. Squitti R, Lupoi D, Pasqualetti P, et al. Elevation of serum copper levels in Alzheimer's disease. Neurology 2002;59:1153-1161.
2. Cuajungco MP, Faget KY, Huang X, Tanzi RE, Bush AI. Metal chelation as therapy for Alzheimer's disease. Ann NY Acad Sci 2000;920:292-304.
3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinic diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
4. Roman GC, Tacamichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report for the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
5. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
6. Jellinger KA. The pathology of ischemic-vascular dementia: an update. J Neurol Sci 2002;203-204:153-157.
7. Serra JA, Dominguez RO, de Lusting ES, et al. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular patients. J Neural Transm 2001;108:1135-1148.